EntryPoint Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Sell |
2,087
-80
| -4% | -$8.35K | 0.11% | 444 |
|
|
2025
Q1 | $253K | Buy |
+2,167
| New | +$253K | 0.12% | 427 |
|
|
2024
Q4 | – | Sell |
-5,156
| Closed | -$463K | – | 724 |
|
|
2024
Q3 | $463K | Buy |
5,156
+4,985
| +2,915% | +$448K | 0.26% | 74 |
|
|
2024
Q2 | $13.8K | Sell |
171
-266
| -61% | -$21.4K | 0.02% | 738 |
|
|
2024
Q1 | $34.9K | Buy |
+437
| New | +$34.9K | 0.03% | 910 |
|